Docket Management
Docket: 01N-0256 - Use of Opiate Analgesics in Various Patient Populations, Including Pediatric Patients
Comment Number: EC -3

Accepted - Volume 1

Comment Record
Commentor Dr. Rodger Orman Date/Time 2001-06-22 00:48:35
Organization Sierra Pain Management Center
Category Health Professional

Comments for FDA General
Questions
1. General Comments Hello, My name is Rodger Orman, MD and I am a practicing physician. I am Board Certified by both the American Board of Family Practice and the American Board of Anesthesiology. I have a chronic pain practice in San Andreas, CA located in the foothills of the Sierras. I see many patients that benefit from the use of oral opiates to treat and manage their chronic non-malignant pain syndromes. I see patients that other physicians do not know how to help, patients that have had 2 or more operations that have left them in chronic agonizing pain. Their lives are distorted by their chronic pain. Their families are affected. Many of these patients benefit greatly from long term oral opiate administration. Products such as Oxycontin, MS-Contin, Methadone, Dilaudid and oral Morphine liquid greatly help these patients. Oxycontin is especially useful due to its versatile dosage forms. Please replace the 160mg extended release tabs on the market so that my patients can take fewer pills. Just because a few people abuse these medications does not justify punishing the law abiding chronic pain patients who must suffer. In short, chronic opiate therapy is a viable option for many patients with non-malignant pain syndromes. These patients benefit from this therapy. Please allow pharmaceutical companies to manufacture and distribute these medications so that I will have useful tools to treat their chronic pain. Thank you.




EC -3